Genetic engineering: This is not the time we use it in clinical applications

Abstract

The evolution of genetic engineering technologies have brought us to a point where we ask a lot of questions and there are many debates on whether we should be using innovative technologies like CRISPR-Cas9 in clinical applications in human embryos. This research essay will argue that no matter how much the technology grows, we have to be 100% sure about its consequences. In order to be sure, there needs to be deep research on those technologies. Do we know enough about the human genome to understand the impact of editing it? It is likely that some countries might consider using these technologies, but while these technologies are fast and cheap, there are consequences in modified embryos that might lead to mutation. This essay will state that scientists should communicate the power of technology and how they can be responsible in using it.